Clinicopathologic and prognostic differences between patients with hepatitis B- and C-related resectable hepatocellular carcinoma.

医学 肝细胞癌 乙型肝炎表面抗原 内科学 胃肠病学 入射(几何) 肝功能 丙型肝炎病毒 乙型肝炎 阶段(地层学) 丙型肝炎 存活率 乙型肝炎病毒 免疫学 病毒 古生物学 物理 光学 生物
作者
Tien Hua Chen,L. H. Tseng,Gar-Yang Chau,Wing-Yiu Lui,Si-Chee Tsay,Kevin W. King,Che Chuan Loong,C Y Hsia,C. Y. Wu
出处
期刊:Journal of the Formosan Medical Association [Elsevier]
卷期号:100 (7): 443-8 被引量:5
标识
摘要

Hepatitis B and C viral infections are important factors in the development of hepatocellular carcinoma (HCC). This study examined the clinicopathologic and prognostic differences in patients with hepatitis B- and C-related resectable HCC.A total of 270 HCC patients who underwent hepatic resection were enrolled. Among these patients, 211 were positive for hepatitis B surface antigen (HBsAg) and 59 were positive for anti-hepatitis C virus antibody (anti-HCV). The clinical manifestations, pathologic features, and treatment outcomes were compared between the HBsAg-positive and anti-HCV-positive groups.Compared to anti-HCV-positive patients, HBsAg-positive patients were significantly younger, had a higher familial incidence of HCC, larger tumor size, and a higher incidence of multiple tumors. HCC patients who were anti-HCV positive had worse liver function and a higher incidence of history of blood transfusion. DNA flow cytometric analysis revealed significantly more proliferative activity in the non-tumor part of the liver in HBsAg-positive HCC patients. The 1-, 3-, and 5-year overall survival rates of HBsAg-positive patients were 79%, 57%, and 48%, respectively, and for anti-HCV-positive patients were 91%, 75%, and 62%, respectively. HBsAg-positive patients had a significantly lower overall survival rate than anti-HCV-positive patients (p = 0.018).HBsAg-positive patients with resectable HCC had a less favorable survival rate after tumor resection than anti-HCV-positive HCC patients. This survival difference might have been related to the relatively advanced stage of disease and the higher proliferative activity of the non-tumor part of the liver in HBsAg-positive HCC patients.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
领导范儿应助酷酷初之采纳,获得10
刚刚
2秒前
2秒前
3秒前
TiY发布了新的文献求助10
4秒前
4秒前
6秒前
Jason完成签到,获得积分20
6秒前
李爱国应助lc采纳,获得10
6秒前
科研小白发布了新的文献求助10
6秒前
明珠发布了新的文献求助10
6秒前
7秒前
积极的誉发布了新的文献求助10
7秒前
传奇3应助文献猪采纳,获得10
8秒前
我不知道a完成签到,获得积分10
8秒前
岩下松风发布了新的文献求助10
8秒前
8秒前
9秒前
花痴的裘完成签到,获得积分10
9秒前
9秒前
9秒前
Jason发布了新的文献求助10
9秒前
10秒前
wanci应助虔三愿采纳,获得10
10秒前
10秒前
11秒前
11秒前
算算完成签到 ,获得积分10
12秒前
CodeCraft应助明亮寻绿采纳,获得10
12秒前
科研小白完成签到,获得积分10
12秒前
myc641完成签到 ,获得积分10
13秒前
YC发布了新的文献求助30
13秒前
样样子发布了新的文献求助10
13秒前
施奇赞完成签到,获得积分10
13秒前
诶呀完成签到 ,获得积分10
14秒前
14秒前
彭于晏应助明珠采纳,获得10
14秒前
glowworm完成签到,获得积分10
14秒前
foreve1发布了新的文献求助10
15秒前
高分求助中
歯科矯正学 第7版(或第5版) 1004
SIS-ISO/IEC TS 27100:2024 Information technology — Cybersecurity — Overview and concepts (ISO/IEC TS 27100:2020, IDT)(Swedish Standard) 1000
Smart but Scattered: The Revolutionary Executive Skills Approach to Helping Kids Reach Their Potential (第二版) 1000
Semiconductor Process Reliability in Practice 720
GROUP-THEORY AND POLARIZATION ALGEBRA 500
Mesopotamian divination texts : conversing with the gods : sources from the first millennium BCE 500
Days of Transition. The Parsi Death Rituals(2011) 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3232433
求助须知:如何正确求助?哪些是违规求助? 2879364
关于积分的说明 8210667
捐赠科研通 2546680
什么是DOI,文献DOI怎么找? 1376287
科研通“疑难数据库(出版商)”最低求助积分说明 647594
邀请新用户注册赠送积分活动 622856